A detailed history of Bill Few Associates, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Bill Few Associates, Inc. holds 12,583 shares of OGN stock, worth $192,268. This represents 0.09% of its overall portfolio holdings.

Number of Shares
12,583
Previous 12,218 2.99%
Holding current value
$192,268
Previous $252,000 4.76%
% of portfolio
0.09%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$18.65 - $23.03 $6,807 - $8,405
365 Added 2.99%
12,583 $240,000
Q2 2024

Jul 16, 2024

BUY
$17.45 - $21.96 $10,836 - $13,637
621 Added 5.35%
12,218 $252,000
Q1 2024

Apr 18, 2024

BUY
$13.78 - $18.8 $159,806 - $218,023
11,597 New
11,597 $218,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.